Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of 130/0.4 Hydroxyethyl Starch vs. Balanced Crystalloid for Intraoperative Fluid Therapy on Major Composite Renal Outcomes After Cardiac Surgery: a Multicenter, Randomized Controlled Trial

NCT07410988 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT07410988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07410988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of 130/0.4 Hydroxyethyl Starch vs. Balanced Crystalloid for Intraoperative Fluid Therapy on Major Composite Renal Outcomes After Cardiac Surgery: a Multicenter, Randomized Controlled Trial
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
June 22, 2026
Completion date
July 31, 2029
Enrollment
1,292 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery